Cornovus Pharmaceuticals

Farmington, United States

Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure.

$500K raised

Jan 2024

Venture - Series Unknown

Health Care Health Diagnostics Medical Medical Device

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cornovus Pharmaceuticals

How much funding has Cornovus Pharmaceuticals raised?

Cornovus Pharmaceuticals has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.

Where is Cornovus Pharmaceuticals headquartered?

Cornovus Pharmaceuticals is headquartered in Farmington, United States.

What does Cornovus Pharmaceuticals do?

Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure.

What stage is Cornovus Pharmaceuticals at?

Cornovus Pharmaceuticals is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 26, 2024.

MLA

"Cornovus Pharmaceuticals — Funding & Investors." VCBacked, January 26, 2024, https://www.vcbacked.co/company/cornovus-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2024). Cornovus Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cornovus-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Cornovus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/cornovus-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 26, 2024.